Title |
Safety of Nifedipine GITS in Stable Angina: The ACTION Trial
|
---|---|
Published in |
Cardiovascular Drugs and Therapy, March 2006
|
DOI | 10.1007/s10557-006-6312-4 |
Pubmed ID | |
Authors |
Philip A. Poole-Wilson, Bridget-Anne Kirwan, Zoltán Vokó, Sophie de Brouwer, Fred J. van Dalen, Jacobus Lubsen, on behalf of the ACTION Investigators |
Abstract |
We describe the safety profile of nifedipine GITS as assessed from adverse events reported in the ACTION trial in which 7,665 patients with stable, symptomatic coronary artery disease were randomly assigned nifedipine GITS or placebo and followed for a mean of 4.9 years. |
Mendeley readers
The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 2% |
Unknown | 42 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 9 | 21% |
Student > Postgraduate | 6 | 14% |
Student > Master | 5 | 12% |
Student > Bachelor | 5 | 12% |
Student > Ph. D. Student | 4 | 9% |
Other | 10 | 23% |
Unknown | 4 | 9% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 16 | 37% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 14% |
Psychology | 4 | 9% |
Agricultural and Biological Sciences | 3 | 7% |
Nursing and Health Professions | 2 | 5% |
Other | 3 | 7% |
Unknown | 9 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2016.
All research outputs
#7,452,489
of 22,783,848 outputs
Outputs from Cardiovascular Drugs and Therapy
#202
of 682 outputs
Outputs of similar age
#23,553
of 67,621 outputs
Outputs of similar age from Cardiovascular Drugs and Therapy
#3
of 6 outputs
Altmetric has tracked 22,783,848 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 682 research outputs from this source. They receive a mean Attention Score of 5.0. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 67,621 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.